EIF5A and central nervous system cancer: This hypothesis is substantiated by the finding that in samples of two non-glioma patients, eIF-5A, eIF-5A2 and DHS expression was mainly detectable in persisting neurons, ependymal and some other brain tissues, but rarely or not at all in astrocytes.